6 recruiting, 3 active not recruiting, 2 completed, 2 not yet recruiting. 8 Phase 2, 6 Phase 3, 2 Phase 1, 1 Not applicable, 1 Phase 4.
Follow Medrol Veriderm: new trials by email Literature Review of Medrol Veriderm trials Research Report on Medrol Veriderm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate Cancer Abiraterone Acetate, Biospecimen Collection, Bone Scan - Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 2 / Phase 3 | Not yet recruiting | ECOG-ACRIN Cancer Research Group | 432 | 2027-01-06 | 2026-10-01 |
| Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL) Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - Stage II T Lymphoblastic Leukemia/Lymphoma, Stage III T Lymphoblastic Leukemia/Lymphoma | Phase 2 / Phase 3 | Not yet recruiting | Children's Oncology Group | 1708 | 2026-08-28 | 2026-07-30 |
| Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial Acetaminophen, Biospecimen Collection, Dexamethasone - Multiple Myeloma | Phase 4 | Recruiting | Emory University | 94 | 2025-09-24 | 2026-07-23 |
| Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia Asparaginase Erwinia chrysanthemi, Biospecimen Collection, Blinatumomab - Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia | Phase 2 | Recruiting | National Cancer Institute (NCI) | 153 | 2025-06-05 | 2026-10-21 |
| Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm Cyclophosphamide, Cytarabine, Dexamethasone - Blastic Plasmacytoid Dendritic Cell Neoplasm | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 40 | 2020-05-29 | 2026-09-14 |
| High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors Methylprednisolone, Prednisone, Quality-of-Life Assessment - Cranial Nerve Disorder, Head and Neck Carcinoma | Phase 1 / Phase 2 | Recruiting | M.D. Anderson Cancer Center | 35 | 2019-10-16 | 2026-06-26 |
| Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Allogeneic Hematopoietic Stem Cell Transplantation, Calaspargase Pegol, Cyclophosphamide - Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia | Phase 3 | Active not recruiting | Children's Oncology Group | 352 | 2017-08-08 | 2026-10-05 |
| Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure Methylprednisolone, Oxygen Therapy, Positive Air Pressure Device - Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Not applicable | Recruiting | M.D. Anderson Cancer Center | 256 | 2015-10-06 | 2026-09-14 |
| Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma Bleomycin Sulfate, Brentuximab Vedotin, Cyclophosphamide - Ann Arbor Stage IIB Hodgkin Lymphoma, Ann Arbor Stage IIIB Hodgkin Lymphoma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 600 | 2015-03-19 | 2026-10-01 |
| Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome Anti-Thymocyte Globulin, Cyclosporine, Filgrastim - Aplastic Anemia, de Novo Myelodysplastic Syndrome | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 140 | 2012-06-25 | 2026-06-22 |
| Gene Therapy for Fanconi Anemia Bone Marrow Aspiration, Filgrastim, Genetically Engineered Hematopoietic Stem Progenitor Cells - Fanconi Anemia | Phase 1 | Terminated | Fred Hutchinson Cancer Center | 3 | 2012-02-22 | 2024-05-17 |
| Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia Allogeneic Hematopoietic Stem Cell Transplantation, Cyclophosphamide, Cytarabine - Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 97 | 2009-09-01 | 2026-10-22 |
| Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Asparaginase, Cyclophosphamide, Cytarabine - Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Phase 2 / Phase 3 | Completed | National Cancer Institute (NCI) | 63 | 2008-07-14 | 2020-04-13 |
| Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Asparaginase, Biospecimen Collection, Bone Marrow Biopsy - Acute Lymphoblastic Leukemia, Acute Undifferentiated Leukemia | Phase 3 | Completed | Children's Oncology Group | 218 | 2008-01-15 | 2024-07-15 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (4) · Burkitt Lymphoma (3) · Leukemia, Biphenotypic, Acute (3) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (3) · Anemia, Aplastic (1) · Blastic Plasmacytoid Dendritic Cell Neoplasm (1) · Cranial Nerve Diseases (1) · Fanconi Anemia (1) · Hematologic Neoplasms (1) · Lymphoma (1) · Multiple Myeloma (1) · Myelodysplastic Syndromes (1) · Oropharyngeal Neoplasms (1) · Prostatic Neoplasms (1)
M.D. Anderson Cancer Center (4) · National Cancer Institute (NCI) (4) · Children's Oncology Group (3) · ECOG-ACRIN Cancer Research Group (1) · Emory University (1) · Fred Hutchinson Cancer Center (1)
United States (12) · Canada (4) · Puerto Rico (4) · Australia (3) · New Zealand (3) · Austria (1) · Belgium (1) · Chile (1) · Czechia (1) · Finland (1) · France (1) · Germany (1) · Hong Kong (1) · Israel (1) · Italy (1)
Andrea Biondi (1) · Erin H Breese (1) · Farhad Ravandi-Kashani (1) · Hans-Peter Kiem (1) · Joanne M Hilden (1) · Joseph Rimando, MD (1) · Katherine A Hutcheson, BA,MS,PHD (1) · Keith J August (1) · Lewis B Silverman (1) · Michael Schweizer (1) · Naveen Pemmaraju (1) · Nisha Rathi (1) · Sharon M Castellino (1) · Tapan M Kadia (1) · William B Slayton (1)
PMID 29618479, PMID 29812996, PMID 32414848, PMID 33242441, PMID 36322844, PMID 36868525, PMID 37505794, PMID 37947987, PMID 39058966, PMID 39058968, PMID 39969278, PMID 40700618, PMID 40990939
U10CA180886 (5), U10CA098543 (2), 2017 (1), P30CA016672 (1), P30CA138292 (1), U10CA032102 (1), U10CA180820 (1), U10CA180888 (1)